| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 1384 |
| 1 | DEXAMETHASONE 1.5 MG | 1384 |
| 2 | BORTEZOMIB | 1098 |
| 3 | PACLITAXEL | 849 |
| 4 | OXALIPLATIN | 842 |
| 5 | CYCLOPHOSPHAMIDE | 808 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 808 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 808 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 707 |
| 9 | FLUOROURACIL | 658 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L DOPA | 15 | 0.0560 |
| 1 | ONTRUZANT | 18 | 0.0345 |
| 2 | TAFASITAMAB-CXIX | 29 | 0.0320 |
| 3 | NELARABINE | 25 | 0.0257 |
| 4 | BRENTUXIMAB VEDOTIN | 213 | 0.0205 |
| 5 | NIMODIPINE | 20 | 0.0178 |
| 6 | CALASPARGASE PEGOL | 14 | 0.0174 |
| 7 | PRETOMANID | 13 | 0.0171 |
| 8 | PANITUMUMAB | 264 | 0.0164 |
| 9 | DATOPOTAMAB DERUXTECAN | 14 | 0.0163 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2483 |
| 1 | Platinum-based Drug [EPC] | 1598 |
| 2 | Microtubule Inhibitor [EPC] | 1276 |
| 3 | Proteasome Inhibitor [EPC] | 1190 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1126 |
| 5 | Alkylating Drug [EPC] | 943 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 937 |
| 7 | Thalidomide Analog [EPC] | 608 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 595 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 564 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 536 | 0.0916 |
| 1 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 2 | CD30-directed Immunoconjugate [EPC] | 213 | 0.0205 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 15 | 0.0132 |
| 4 | Proteasome Inhibitor [EPC] | 1190 | 0.0104 |
| 5 | Endoglycosidase [EPC] | 16 | 0.0086 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 595 | 0.0080 |
| 7 | Microtubule Inhibitor [EPC] | 1276 | 0.0077 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 333 | 0.0070 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 43 | 0.0068 |